Literature DB >> 8566061

Interleukin-10 inhibits cytokine generation from mast cells.

M Arock1, C Zuany-Amorim, M Singer, M Benhamou, M Pretolani.   

Abstract

This report examines the effects of recombinant murine interleukin-10 (rmIL-10) on antigen-induced beta-hexosaminidase, leukotriene (LT)C4 and cytokine release from mouse bone marrow-derived mast cells (BMMC). BMMC sensitized to hapten-monoclonal IgE directed against dinitrophenol-bovine serum albumin (DNP-BSA) and challenged with 10 ng/ml DNP-BSA generated beta-hexosaminidase and LTC4-like material which was followed by tumor necrosis factor-alpha (TNF-alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA expression and protein release. Incubation of BMMC with 1-100 ng/ml rmIL-10 inhibited cytokine generation, without affecting beta-hexosaminidase and LTC4-like material release. TNF-alpha, but not GM-CSF mRNA expression, was also diminished in rmIL-10-treated BMMC, suggesting that down-regulation of cytokine production by rmIL-10 involves different mechanisms. These results identify a novel biological action of IL-10 as an inhibitor of cytokine production by stimulated mast cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8566061     DOI: 10.1002/eji.1830260126

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Allergen-specific CD8(+) T cells and atopic disease.

Authors:  Suranjith L Seneviratne; Louise Jones; Abigail S King; Antony Black; Sheila Powell; Andrew J McMichael; Graham S Ogg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium.

Authors:  Olivia L Wei; Ashley Hilliard; Daniel Kalman; Melanie Sherman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue.

Authors:  S C Bischoff; A Lorentz; S Schwengberg; G Weier; R Raab; M P Manns
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

4.  IL-10 Enhances IgE-Mediated Mast Cell Responses and Is Essential for the Development of Experimental Food Allergy in IL-10-Deficient Mice.

Authors:  Stephanie H Polukort; Jeffrey Rovatti; Logan Carlson; Chelsea Thompson; Jennifer Ser-Dolansky; Shannon R M Kinney; Sallie S Schneider; Clinton B Mathias
Journal:  J Immunol       Date:  2016-05-06       Impact factor: 5.422

5.  Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice.

Authors:  I Fenoy; M Giovannoni; E Batalla; V Martin; F M Frank; I Piazzon; A Goldman
Journal:  Clin Exp Immunol       Date:  2008-11-20       Impact factor: 4.330

6.  Role of interleukin 10 in specific immunotherapy.

Authors:  C A Akdis; T Blesken; M Akdis; B Wüthrich; K Blaser
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

7.  Characterisation of interleukin-10 expression on different vascular structures in allergic nasal mucosa.

Authors:  Barbara Muller; Danielle van Egmond; Esther Jj de Groot; Wytske J Fokkens; Cornelis M van Drunen
Journal:  Clin Transl Allergy       Date:  2014-01-10       Impact factor: 5.871

Review 8.  Chronic inflammation and asthma.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Mutat Res       Date:  2009-09-19       Impact factor: 2.433

9.  Interleukin-4 promotes human CD8 T cell expression of CCR7.

Authors:  Suranjith L Seneviratne; Antony P Black; Louise Jones; Kati di Gleria; Abigail S Bailey; Graham S Ogg
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

10.  Immunological parameters and gene polymorphisms (C-590T IL4, C-597A IL10) in severe bronchial asthma in children from the Krasnoyarsk region, West Siberia.

Authors:  Marina V Smolnikova; Svetlana V Smirnova; Maxim B Freidin; Olga S Tyutina
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.